1. Volume 151, Issue 6, Pages 1113-1121 (December 2016)
Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea- Predominant Irritable Bowel Syndrome 
Anthony Lembo, Mark Pimentel, Satish S. Rao, Philip Schoenfeld, Brooks Cash, Leonard B. Weinstock, Craig Paterson, Enoch Bortey, William P. Forbes 
Gastroenterology 
Volume 151, Issue 6, Pages (December 2016)
DOI: /j.gastro
Copyright © 2016 AGA Institute Terms and Conditions

2. Figure 1
Study design (A) and mean baseline IBS symptom severity for patients entering the open-label treatment phase versus the same patients entering the double-blind, first repeat treatment phase (n = 636) (B). DB, double-blind; EOS, end of study; IBS, irritable bowel syndrome; OL, open-label; SC, stool sample collection time point.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2016 AGA Institute Terms and Conditions

3. Figure 2
Change from baseline in average daily abdominal pain scores during the first and second repeat treatment double-blind phases. aStatistically significant difference vs placebo. Data were analyzed using last observation carried forward methodology.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2016 AGA Institute Terms and Conditions